Drugs that need prior authorization
i
CMS's monthly Part D formulary files: for each plan, its formulary, and for each drug on the formulary, whether it needs prior authorization, step therapy or a quantity limit. A drug here is one RxNorm drug concept (an ingredient, strength and form); shares are of the drugs on the plan's formulary.
From October each year the files describe the next year's plans, which go on sale then, so a month-to-month change is shown only between months of the same plan year. Members: each plan's enrollment that month, or the latest month we have; for next year's plans, today's enrollment of the same contract and plan number, so new plans count zero until they have members. Contract and parent figures are member-weighted across their plans.
The share of drugs needing approval says how much of the list carries a restriction, not how often members meet one: a plan can restrict many rarely used drugs, or a few common ones.
Share of covered drugs needing prior authorization, by month
Member-weighted across plans. Each line is one plan year; next year's plans appear from October.
By contract: Medica Holding Company, October 2026
| Contract | Members | Plans | Drugs on formulary | Prior authorizationshare of drugs | ChangeiChange Change in the share of drugs needing prior authorization since the month before (Sep), in percentage points. Only months of the same plan year are compared: October 2026 is the first month of the 2027 plan year, so there's nothing to compare yet. |
Step therapy | Quantity limit |
|---|---|---|---|---|---|---|---|
| H8889 plansMedica Holding Company | 24,463 | 16 | 3,281 | 28.3% | — | 0.7% | 36% |
| H2458 plansMedica Holding Company | 16,577 | 1 | 3,452 | 28.2% | — | 0.6% | 37% |
| H2450 plansMedica Holding Company | 15,595 | 4 | 3,281 | 28.3% | — | 0.7% | 36% |
| H9096 plansMedica Holding Company | 10,875 | 4 | 3,131 | 26.7% | — | 0.1% | 49% |
"plans" lists a contract's plans. Members are projected from todays enrollment.